Navigation Links
Boston Scientific's Alair® Bronchial Thermoplasty System Achieves Important Reimbursement Milestones
Date:1/4/2012

vary materially from the expectations and projections expressed or implied by our forward-looking statements.  These factors, in some cases, have affected and in the future (together with other factors) could affect our ability to implement our business strategy and may cause actual results to differ materially from those contemplated by the statements expressed in this press release.  As a result, readers are cautioned not to place undue reliance on any of our forward-looking statements. 

Factors that may cause such differences include, among other things: future economic, competitive, reimbursement and regulatory conditions; new product introductions; demographic trends; intellectual property; litigation; financial market conditions; and future business decisions made by us and our competitors.  All of these factors are difficult or impossible to predict accurately and many of them are beyond our control.  For a further list and description of these and other important risks and uncertainties that may affect our future operations, see Part I, Item 1A – Risk Factors in our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission, which we may update in Part II, Item 1A – Risk Factors in Quarterly Reports on Form 10-Q we have filed or will file hereafter.  We disclaim any intention or obligation to publicly update or revise any forward-looking statements to reflect any change in our expectations or in events, conditions or circumstances on which those expectations may be based, or that may affect the likelihood that actual results will differ from those contained in the forward-looking statements.  This cautionary statement is applicable to all forward-looking statements contained in this document.

CONTACT:   

Eric Olson
336-293-4393 (office)
Media Relations
Boston Scientific Corporation

SOURCE Boston Scientific
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Boston Scientific Announces Schedule for European Society of Cardiology Congress 2007
3. Boston University Biomedical Engineers Find Chink in Bacterias Armor
4. Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007
5. Preliminary Results of Randomized Pilot Study Show Comparable Efficacy for OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) and Boston Scientifics Taxus(R) Stent in Patients at High Risk of Restenosis
6. Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures
7. Boston Scientifics Next-Generation Stent Shows Improved Clinical Outcomes in Complex Lesions
8. Positive Five-Year Safety Data for TAXUS(R) Stent Reported in Boston Scientific Trial
9. Boston Scientific Carotid Artery Stenting Trials Produce Positive Three-Year Results
10. Award-Winning Medicine Wheel Returns to the Cyclorama at the Boston Center for the Arts on Dec. 1 for 24-hour Vigil Recognizing World AIDS Day
11. Boston Scientific Announces CE Mark Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... SHENZHEN, China, Aug. 28, 2014 China ... ("Nepstar" or the "Company"), a leading retail drugstore ... directly operated stores, today announced its unaudited financial ... Financial HighlightsFor the quarter ended June 30, ... RMB686.6 million (US$110.7 million) compared to RMB638.8 million in ...
(Date:8/27/2014)... British Columbia and MENLO PARK, ... Pharmaceuticals, Inc. , (OTCQB: DMPI), developer of advanced ... company at the 16th Annual Rodman & Renshaw Global ... Co., LLC. The presentation will take place Tuesday, September 9th ... (4th floor) at the New York Palace Hotel in ...
(Date:8/27/2014)... BURLINGTON, Mass. , Aug. 27, 2014 /PRNewswire/ ... six different specialties (medical oncology, hematology-oncology, rheumatology, gastroenterology, ... of clinical trials that a biosimilar has been ... which biosimilar product they choose to prescribe. ... Advisory Service report entitled Acceptance of ...
Breaking Medicine Technology:China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 2China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 3China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 4China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 5China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 6China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 7China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 8China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 9China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 10China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 11DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference 2DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference 3DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference 4Surveyed Physicians Expect to Choose Between Future Biosimilars Based on Robustness and Number of Clinical Trials 2
(Date:8/28/2014)... Hastings and Hastings, a Phoenix Arizona ... in the industry is pleased to report having saved ... approximately $125,000. This is exciting news for existing clients ... well defined proof that Hastings and Hastings stands behind ... fees. Saving clients money when it comes to settlements ...
(Date:8/28/2014)... 28, 2014 InventHelp, a ... clients, an inventor from California, has designed an alternative ... invention is patented. , The “Abdominal Swimming Support” is ... risk of injuries from physical activity if one is ... or muscular atrophy. Ideal for use as a ...
(Date:8/28/2014)... Baltimore, MD (PRWEB) August 28, 2014 ... has received Diamond level Allergan Privilege Program status ... widely used treatments as Botox, Juvederm, and Voluma. Maryland ... exemplary and prolific use of these treatments. The dermatologists ... in injectable treatments, and are one of the leading ...
(Date:8/28/2014)... 2014 Altec Products, Inc., a ... announced today that they have been awarded the ... of the International Association of Microsoft Channel Partners ... founded in 1994, providing Microsoft Partners with a ... community at large while facilitating mutual growth and ...
(Date:8/28/2014)... 2014 Dr. Bryan McIntosh of Bellevue, ... guide to the tummy tuck cosmetic procedure, leading ... procedure itself, and how to recover well afterwards. ... Dr. McIntosh also discusses how to have accurate expectations ... the procedure is as successful as possible. , To ...
Breaking Medicine News(10 mins):Health News:Hastings and Hastings Is Pleased To Report Having Saved A Client $13,750 On A Settlement Of $125,000 2Health News:Hastings and Hastings Is Pleased To Report Having Saved A Client $13,750 On A Settlement Of $125,000 3Health News:InventHelp® Client Patents “Abdominal Swimming Support” – Invention Could Serve as an Alternative Flotation Device 2Health News:Maryland Laser Skin and Vein Receives Diamond Status From Allergan 2Health News:Altec and Bond Consulting Services Receive Award from the International Association of Microsoft Channel Partners SoCal Chapter 2Health News:Altec and Bond Consulting Services Receive Award from the International Association of Microsoft Channel Partners SoCal Chapter 3Health News:The Ultimate Guide to the Tummy Tuck Surgery eBook is Released by Dr. Bryan McIntosh 2
... healthy lifestyle that includes not smoking, limiting alcohol intake, and ... the journal PLoS Medicine , Wei Zheng, M.D., Ph.D., ... results from a large study quantifying the impact of combining ... lifestyle pattern being normal weight, having low belly fat, ...
... study released today by the American Lung Association, and ... helping smokers quit not only saves lives but also ... titled Smoking Cessation: the Economic Benefits, provides a nationwide ... smoking with the economic benefits of states providing cessation ...
... New research findings from the Universit de Montral reveals ... understand and use irony. This study, published recently in ... way parents communicate with their family. "Previous studies ... eight or ten," says Stephanie Alexander, a postdoctoral student ...
... really takes for seniors to make ends meet in each ... state Capitol in Sacramento. The release is ... (Elder Index), a tool that measures the actual costs of ... replacing federal poverty level (FPL) guidelines as a new standard ...
... HealthDay Reporter , TUESDAY, Sept. 14 (HealthDay News) ... when in vitro fertilization is done during the springtime. ... highest in the spring -- 73.5 percent vs. 67.9 ... than the summer and fall rates. "Epidemiolgists have ...
... TUESDAY, Sept. 14 (HealthDay News) -- The risk of tendon ... higher levels of estrogen, a small European study suggests. ... to test estrogen levels in order to identify at-risk athletes ... training program, said Katherine E. Burgess, of the University of ...
Cached Medicine News:Health News:Benefits of healthy lifestyle factors stronger in combination 2Health News:New study finds positive return on investment for states that invest in quit smoking treatments 2Health News:New study finds positive return on investment for states that invest in quit smoking treatments 3Health News:Report shows federal poverty guidelines leave state's seniors destitute 2Health News:Report shows federal poverty guidelines leave state's seniors destitute 3Health News: In Vitro Fertilization Success Rate Higher in Spring, Study Suggests 2Health News: In Vitro Fertilization Success Rate Higher in Spring, Study Suggests 3
HbA1c / HbCalibrator...
Heparin-Platelet Factor 4 Induced Antibody...
Multi-constituent Calibration Plasma for Functional Assays of Coagulation Parameters on STA© Analyzers....
Control Plasma for Assays of Unfractionated Heparins (UH) using Anti-Xa Methodon STA© Analyzers....
Medicine Products: